NCT02345291 - Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Diabetic Peripheral Neuropathic Pain

Interventions

DRUG

NRD135S.E1

A small chemical entity for treatment of neuropathic pain NRD135S.E1

DRUG

Placebo to match NRD135S.E1

Placebo capsule to match NRD135S.E1 capsules

Trial Locations (10)

Diabetes clinic, Lin Medical Center, Haifa

Meir Medical Center, Endocrynology, diabetes and metabolism Unit, Kfar Saba

Diabetes Department Migdal Hamea Clalit health services, Tel Aviv

DMC Medical Center, Tel Aviv

Diabetic and Endocrinology clinic, Clalit health services, Jerusalem

Diabetes and Endocrinology clinic, Bat-Yamon Medical center, Clalit health services, Bat Yam

Rambam Medical Center, Diabetic Endocrine unit, Haifa

Wolfson Medical Center, Holon

Ziv Medical Center, Endocrinology Unit, Safed

Sorasky Medical Center, Diabetic unit, Tel Aviv